Market Place
Sourcing Support
Akeso`s Biologic Penpulimab Receives Suppl Approval in US
23 Apr 2025 //
FDA
Kashiv Bio`s Biologic FYLNETRA Receives Suppl Approval in US
23 Apr 2025 //
FDA
BeiGene`s Biologic Tevimbra Receives Suppl Approval in US
22 Apr 2025 //
FDA
Amgen`s Biologic Bkemv Receives Suppl Approval in US
18 Apr 2025 //
FDA
Janseen`s Biologic Simponi Aria Receives Suppl Approval in US
18 Apr 2025 //
FDA
Centocor`s Biologic Simponi Receives Suppl Approval in US
18 Apr 2025 //
FDA
Aurobindo`s Generics Esomeprazole Receives Approval in US
15 Apr 2025 //
FDA
Fresenius Kabi`s Biologic Otulfi Receives Suppl Approval in US
14 Apr 2025 //
FDA
Micro Labs`s Generics Latanoprost Receives Approval in US
14 Apr 2025 //
FDA
BMS`s Biologic Opdivo Receives Suppl Approval in US
11 Apr 2025 //
FDA
BMS`s Biologic Yervoy Receives Suppl Approval in US
11 Apr 2025 //
FDA
Argenx`s Biologic Vyvgart Hytrulo Receives Suppl Approval in US
10 Apr 2025 //
FDA
Eli Lilly`s Biologic Cyramza Receives Suppl Approval in US
07 Apr 2025 //
FDA
Dermavant Sciences`s Nduvra Receives Approval in Canada
04 Apr 2025 //
HEALTH CANADA
Viela Bio`s Biologic Uplizna Receives Suppl Approval in US
03 Apr 2025 //
FDA
Janseen Biotech`s Biologic Stelara Receives Approval in US
01 Apr 2025 //
FDA
Centocor`s Biologic Stelara Receives Approval in US
01 Apr 2025 //
FDA
Fresenius Kabi`s Biologic Denosumab Receives Approval in US
25 Mar 2025 //
FDA
Fresenius Kabi`s Biologic Conexxence Receives Approval in US
25 Mar 2025 //
FDA
Fresenius Kabi`s Biologic Bomyntra Receives Approval in US
25 Mar 2025 //
FDA
AMTA`s Generics Diltiazem HCl Receives Approval in US
24 Mar 2025 //
FDA
Merck`s Biologic Keytruda Receives Approval in US
19 Mar 2025 //
FDA
Biogen`s Biologic Tysabri Receives Suppl Approval in US
18 Mar 2025 //
FDA
Sandoz`s Biologic Imuldosa Receives Suppl Approval in US
17 Mar 2025 //
FDA
Biogen`s Skyclarys Receives Approval in Canada
13 Mar 2025 //
HEALTH CANADA
Lupin`s Generics Rivaroxaban Receives Tentative Approval in US
03 Mar 2025 //
FDA
Lupin`s Generics Rivaroxaban Receives Approval in US
03 Mar 2025 //
FDA
Taro`s Generics Rivaroxaban Receives Approval in US
03 Mar 2025 //
FDA
Taro`s Generics Rivaroxaban Receives Tentative Approval in US
03 Mar 2025 //
FDA
MSN`s Generics Lofexidine HCl Receives Approval in US
24 Feb 2025 //
FDA
MSN`s Generics Posaconazole Receives Approval in US
24 Feb 2025 //
FDA
Gland Pharma`s Generics Lofexidine HCl Receives Approval in US
24 Feb 2025 //
FDA
Alvotech`s Biologic Simlandi Receives Suppl Approval in US
14 Feb 2025 //
FDA
Janssen biotech`s Biologic Rybrevant Receives Suppl Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Receives Approval in US
14 Feb 2025 //
FDA
Samsung Bioepis`s Biologic Xbryk Receives Approval in US
14 Feb 2025 //
FDA
Sanofi`s Biologic Merilog Solostar Receives Approval in US
14 Feb 2025 //
FDA
Sandoz`s Biologic Enzeevu Receives Suppl Approval in US
10 Feb 2025 //
FDA
Torrent Pharma`s Generics Silodosin Receives Approval in US
10 Feb 2025 //
FDA
Incyte Corporation`s Zynyz Receives Approval in Canada
06 Feb 2025 //
HEALTH CANADA
Saba`s Generics Azilsartan Receive Tentative Approval in US
06 Feb 2025 //
FDA
Mylan Pharma`s Biologic Hulio Receives Suppl Approval in US
05 Feb 2025 //
FDA
Square Pharma`s Generics Methimazole Receives Approval in US
05 Feb 2025 //
FDA
Gland`s Generics Methylnaltrexone Br Receive Tentative Approval in US
05 Feb 2025 //
FDA
Natco Pharma`s Generics Bosentan Receives Approval in US
05 Feb 2025 //
FDA
Caplin`s Generics Procainamide HCl Receives Approval in US
04 Feb 2025 //
FDA
Torrent Pharm`s Generics Ranolazine Receives Approval in US
04 Feb 2025 //
FDA
Dr. Reddy`s Generics Linagliptin Receive Tentative Approval in US
04 Feb 2025 //
FDA
Genentech`s Biologic Susvimo Receives Suppl Approval in US
04 Feb 2025 //
FDA
Navinta`s Generics Sevelamer HCl Receives Approval in US
03 Feb 2025 //
FDA
Aucta`s Generics Arformoterol Receives Approval in US
03 Feb 2025 //
FDA
Zenara`s Generics Nitazoxanide Receives Approval in US
03 Feb 2025 //
FDA
Mylan`s Generics Dabigatran Receives Approval in US
03 Feb 2025 //
FDA
Alkem Lab`s Generics Nimodipine Receives Approval in US
22 Jan 2025 //
FDA
Kyowa Kirin`s Biologic Poteligeo Receives Suppl Approval in US
22 Jan 2025 //
FDA
Alkem`s Generics Azilsartan, Chlorthalidone Receives Approval in US
21 Jan 2025 //
FDA
Hikma Pharma`s Generics Ertugliflozin Receives Approval in US
21 Jan 2025 //
FDA
Annora`s Generics Darunavir Receive Tentative Approval in US
21 Jan 2025 //
FDA
Daiichi Sankyo`s Biologic Datroway Receives Approval in US
17 Jan 2025 //
FDA
Biocon`s Generics Dasatinib Receive Tentative Approval in US
17 Jan 2025 //
FDA
